OncoCyte
Oncocyte VitaGraft Kidney Transplant Test Receives CMS Coverage
Palmetto issued a positive coverage decision for VitaGraft Kidney under the same LCD covering CareDx's HeartCare transplant surveillance service.
In Brief This Week: Labcorp; T2 Biosystem; MiRxes; Accelerate Diagnostics; and More
News items for the week of Aug. 7, 2023.
Oncocyte Initiates 1-for-20 Reverse Stock Split
The split will reduce the number of outstanding shares of Oncocyte's common stock to approximately 8.2 million, subject to potential adjustments.
In Brief This Week: Thermo Fisher Scientific, Danaher, Accelerate Diagnostics, Oncocyte, More
News items for the week of May 8, 2023.
Top Five Articles on 360Dx Last Week: FDA Clearances in March; Oncocyte Layoffs; and More
Last week, readers were most interested in a story about 510(k) clearances issued by the FDA last month.
Apr 13, 2023
Oncocyte Lays off 20 Percent of Workforce
Apr 14, 2022